ALCHEMIST - A151216: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) A screening trial for A081105 and E4512

About this Study

The purpose of this research study is to examine lung cancer patients' surgically removed tumors for certain genetic changes, and to possibly refer these patients to a treatment study with drugs that may specifically target tumors that have these genetic changes. 

Sponsor Protocol ID:A151216
IRB Number:2015-0219
Actively Enrolling
Early Phase 1
July 30, 2019
Eligibility Criteria
18 years old
100 years old
Both Male and Female

Inclusion CriteriaThis study will be available to all eligible patients, regardless of race, gender, or ethnic origin.  

Categories Click category to view its trials.
Participating Locations
Cancer Center and Research Institute - UMMC
University Hospital - UMMC
Contact Information
Contact Name: Jennifer Barnes
Phone Number: 601-815-4540
Principal Investigator:John Ruckdeschel
How to participate in our Clinical Trials